Physician profile
Evan Berger
NPI 1326501446
$3,206.48
in general payments reported to CMS, 2019-2025
9 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,809 · 2024: $253 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,431 · Education: $1,016 · Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,430.72 |
| Education | $1,016.15 |
| Food and Beverage | $759.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,103.68 | 2023 | Senza |
| Medtronic, INC. | $509.51 | 2023 | Vanta Adaptivestim |
| Boston Scientific Corporation | $162.02 | 2023 | |
| Spr Therapeutics, INC | $119.13 | 2024 | Sprint Pns System |
| Vertos Medical, INC. | $116.02 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $98.88 | 2025 | |
| Merck Sharp & Dohme LLC | $38.85 | 2024-2025 | Bridion |
| Abbvie INC. | $33.84 | 2023 | Botox |
| Averitas Pharma INC. | $24.55 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.